FDA Clears New Ultrasound Systems from Esaote

The Food and Drug Administration has granted 510(k) clearance for the MyLab A50 and MyLab A70 ultrasound devices that combine advanced imaging and artificial intelligence (AI) capabilities to facilitate improved diagnostic precision. Providing detailed assessment and multiparametric evaluations, the MyLab A50 and MyLab A70 ultrasound platforms facilitate attenuation imaging, liver elastography and cardiology applications such as strain analysis, according to Esaote, the manufacturer of the devices. Esaote added that the battery-operated compact design of the devices enable portability in a variety of clinical settings and ease of use for increased efficiency. “The new A-series emphasizes user experience with a diverse range of interface options, including both a conventional and touch control panel. The devices boast an intuitive, easy-to-clean design that allows clinicians to operate efficiently and confidently,” noted Thomas Will, the director of ultrasound sales at Esaote North America.